| Dr Christopher D Petrus, MD | |
|
8720 Fairhope Ave, Fairhope, AL 36532-3608 | |
| (251) 990-2241 | |
| (251) 990-2242 |
| Full Name | Dr Christopher D Petrus |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 28 Years |
| Location | 8720 Fairhope Ave, Fairhope, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982667622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | AL29300 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thomas Hospital | Fairhope, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Associates Of Mobile, P.a. | 3870497951 | 49 |
News Archive
Protalix BioTherapeutics, Inc., announced today positive preliminary data from the first 15 patients that completed the Company's nine month, worldwide, multi-center, open-label, switchover trial of taliglucerase alfa for the treatment of Gaucher disease under a protocol cleared by the U.S. Food and Drug Administration (FDA). The data indicate that patients can safely be switched to taliglucerase alfa from imiglucerase (Cerezyme®).
Amnesty International called on President Obama today to quickly establish an Office of Maternal Health to lead government action to reduce soaring pregnancy-related complications and maternal deaths nationwide. The human rights organization said the government must take immediate steps to stop the loss of two to three women every day and reduce the risk of complications that now affect one-third of all pregnant women - 1.7 million women a year.
A new clinical trial dispels the hypothesis that the diabetes drug metformin could help exercising seniors gain more muscle mass.
Housing homeless people with severe mental illness even more cost-effective than housing people with moderate needs
Women that underwent extreme physical training and completed a transantarctic expedition did not show any more negative health effects than would be expected in men, according to a study presented at the Society for Endocrinology annual conference in Glasgow.
› Verified 6 days ago
| Entity Name | Urology Associates Of Mobile, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194828368 PECOS PAC ID: 3870497951 Enrollment ID: O20031120000743 |
News Archive
Protalix BioTherapeutics, Inc., announced today positive preliminary data from the first 15 patients that completed the Company's nine month, worldwide, multi-center, open-label, switchover trial of taliglucerase alfa for the treatment of Gaucher disease under a protocol cleared by the U.S. Food and Drug Administration (FDA). The data indicate that patients can safely be switched to taliglucerase alfa from imiglucerase (Cerezyme®).
Amnesty International called on President Obama today to quickly establish an Office of Maternal Health to lead government action to reduce soaring pregnancy-related complications and maternal deaths nationwide. The human rights organization said the government must take immediate steps to stop the loss of two to three women every day and reduce the risk of complications that now affect one-third of all pregnant women - 1.7 million women a year.
A new clinical trial dispels the hypothesis that the diabetes drug metformin could help exercising seniors gain more muscle mass.
Housing homeless people with severe mental illness even more cost-effective than housing people with moderate needs
Women that underwent extreme physical training and completed a transantarctic expedition did not show any more negative health effects than would be expected in men, according to a study presented at the Society for Endocrinology annual conference in Glasgow.
› Verified 6 days ago
| Entity Name | Fairhope Urology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811257926 PECOS PAC ID: 8123284973 Enrollment ID: O20120723000531 |
News Archive
Protalix BioTherapeutics, Inc., announced today positive preliminary data from the first 15 patients that completed the Company's nine month, worldwide, multi-center, open-label, switchover trial of taliglucerase alfa for the treatment of Gaucher disease under a protocol cleared by the U.S. Food and Drug Administration (FDA). The data indicate that patients can safely be switched to taliglucerase alfa from imiglucerase (Cerezyme®).
Amnesty International called on President Obama today to quickly establish an Office of Maternal Health to lead government action to reduce soaring pregnancy-related complications and maternal deaths nationwide. The human rights organization said the government must take immediate steps to stop the loss of two to three women every day and reduce the risk of complications that now affect one-third of all pregnant women - 1.7 million women a year.
A new clinical trial dispels the hypothesis that the diabetes drug metformin could help exercising seniors gain more muscle mass.
Housing homeless people with severe mental illness even more cost-effective than housing people with moderate needs
Women that underwent extreme physical training and completed a transantarctic expedition did not show any more negative health effects than would be expected in men, according to a study presented at the Society for Endocrinology annual conference in Glasgow.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher D Petrus, MD 8720 Fairhope Ave, Fairhope, AL 36532-3608 Ph: (251) 990-2241 | Dr Christopher D Petrus, MD 8720 Fairhope Ave, Fairhope, AL 36532-3608 Ph: (251) 990-2241 |
News Archive
Protalix BioTherapeutics, Inc., announced today positive preliminary data from the first 15 patients that completed the Company's nine month, worldwide, multi-center, open-label, switchover trial of taliglucerase alfa for the treatment of Gaucher disease under a protocol cleared by the U.S. Food and Drug Administration (FDA). The data indicate that patients can safely be switched to taliglucerase alfa from imiglucerase (Cerezyme®).
Amnesty International called on President Obama today to quickly establish an Office of Maternal Health to lead government action to reduce soaring pregnancy-related complications and maternal deaths nationwide. The human rights organization said the government must take immediate steps to stop the loss of two to three women every day and reduce the risk of complications that now affect one-third of all pregnant women - 1.7 million women a year.
A new clinical trial dispels the hypothesis that the diabetes drug metformin could help exercising seniors gain more muscle mass.
Housing homeless people with severe mental illness even more cost-effective than housing people with moderate needs
Women that underwent extreme physical training and completed a transantarctic expedition did not show any more negative health effects than would be expected in men, according to a study presented at the Society for Endocrinology annual conference in Glasgow.
› Verified 6 days ago
Mr. Michael T Niehuss, CRNP Urology Medicare: Not Enrolled in Medicare Practice Location: 8720 Fairhope Ave, Fairhope, AL 36532 Phone: 251-990-2441 Fax: 251-990-2242 | |
Lisa Rae Bailey, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 150 S Ingleside St, Fairhope, AL 36532 Phone: 251-660-5930 Fax: 251-660-5931 | |
James Otis Gordon, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 210 S Mobile St, #23, Fairhope, AL 36532 Phone: 251-928-0611 | |
Christopher Keel, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 150 S Ingleside St, Fairhope, AL 36532 Phone: 251-660-5930 Fax: 516-605-9312 |